论文部分内容阅读
噻烷丙胺(tiapamil)是一种新型钙拮抗剂。作者用该药对门诊的20例患轻至中度原发性高血压的成年病人进行了58周的治疗试验,以对该药的抗高血压作用和对代谢的影响作评价。
Tiapamil is a new type of calcium antagonist. The authors used this drug to treat an outpatient 20 adults with mild-to-moderate essential hypertension for a 58-week treatment trial to evaluate the antihypertensive effects and metabolic effects of the drug.